LEADER 02801nam 2200589 a 450 001 9910456157803321 005 20200520144314.0 010 $a1-282-75996-5 010 $a9786612759963 010 $a1-84816-426-2 035 $a(CKB)2490000000001614 035 $a(StDuBDS)AH24682632 035 $a(SSID)ssj0000427918 035 $a(PQKBManifestationID)11284054 035 $a(PQKBTitleCode)TC0000427918 035 $a(PQKBWorkID)10413677 035 $a(PQKB)11029551 035 $a(MiAaPQ)EBC1681710 035 $a(WSP)00000500 035 $a(Au-PeEL)EBL1681710 035 $a(CaPaEBR)ebr10422672 035 $a(CaONFJC)MIL275996 035 $a(OCoLC)729020357 035 $a(EXLCZ)992490000000001614 100 $a20091130d2009 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aSelected papers on the periodic table$b[electronic resource] /$fby Eric Scerri 210 $aLondon $cImperial College Press ;$aSingapore ;$aHackensack, NJ $cDistributed by World Scientific Pub.$dc2009 215 $a1 online resource (ix, 143 p. ) $cill 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a1-84816-425-4 320 $aIncludes bibliographical references. 327 $aPaper 1. Chemistry, spectroscopy, and the question of reduction -- Paper 2. The electronic configuration model, quantum mechanics and reduction -- Paper 3. The periodic table and the electron -- Paper 4. How good is the quantum mechanical explanation of the periodic system? -- Paper 5. Prediction and the periodic table -- Paper 6. L?owdin's remarks on the Aufbau principle and a philosopher's view of Ab Initio quantum chemistry -- Paper 7. Mendeleev's legacy -- Paper 8. The role of triads in the evolution of the periodic table : past and present -- Paper 9. The past and future of the periodic table -- Paper 10. The dual sense of the term "element," attempts to derive the Madelung rule, and the optimal form of the periodic table, if any. 330 $aContains key articles by Eric Scerri, one of the leading authority on the history and philosophy of the periodic table of the elements. This book explores a range of topics such as the historical evolution of the periodic system as well as its philosophical status and its relationship to modern quantum physics. 606 $aPeriodic law 606 $aChemical elements 608 $aElectronic books. 615 0$aPeriodic law. 615 0$aChemical elements. 676 $a546/.8 700 $aScerri$b Eric R$0306565 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910456157803321 996 $aSelected papers on the periodic table$92079781 997 $aUNINA LEADER 03016nam 2200577Ia 450 001 9910452082503321 005 20200520144314.0 010 $a1-280-50667-9 010 $a9786610506675 010 $a0-309-65577-3 035 $a(CKB)1000000000465560 035 $a(EBL)3378103 035 $a(SSID)ssj0000137676 035 $a(PQKBManifestationID)11158795 035 $a(PQKBTitleCode)TC0000137676 035 $a(PQKBWorkID)10088602 035 $a(PQKB)10195975 035 $a(MiAaPQ)EBC3378103 035 $a(Au-PeEL)EBL3378103 035 $a(CaPaEBR)ebr10132071 035 $a(CaONFJC)MIL50667 035 $a(OCoLC)923275635 035 $a(EXLCZ)991000000000465560 100 $a20060809d2006 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aDeveloping a national registry of pharmacologic and biologic clinical trials$b[electronic resource] $eworkshop report /$fCommittee on Clinical Trial Registries, Board on Health Sciences Policy, Institute of Medicine of the National Academies 210 $aWashington, D.C. $cNational Academies Press$dc2006 215 $a1 online resource (124 p.) 300 $aDescription based upon print version of record. 311 $a0-309-10078-X 320 $aIncludes bibliographical references (p. 47-48). 327 $a""Front Matter""; ""Independent Report Reviewers ""; ""Foreword ""; ""Preface ""; ""Contents ""; ""List of Tables ""; ""1 Summary ""; ""2 The Need for Clinical Trial Registries ""; ""3 Current Registry Activities ""; ""4 Content of a Clinical Trial Registry ""; ""5 Implementation Issues ""; ""6 Conclusion and Next Steps ""; ""References ""; ""APPENDIXES""; ""A Participants and Invited Experts Between December 1, 2004, and June 27, 2005 ""; ""B Workshop Agenda, Speakers, Panelists, and Participants: June 27, 2005 "" 327 $a""C Section 113 of the Food and Drug Administration Modernization Act of 1997 and Guidance for Industry: Information Programs on Clinical Trials for Serious or Life- Threatening Diseases and Conditions. U.S. Department of Health and Human Services.""""D Published Journal Editorials ""; ""E Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases""; ""F Illustrative Data Fields for the Results Summary (based on ICH E3 template) ""; ""G Biographical Sketches of Committee Members "" 606 $aClinical trials$zUnited States 606 $aClinical medicine$xResearch 608 $aElectronic books. 615 0$aClinical trials 615 0$aClinical medicine$xResearch. 676 $a615.5072 712 02$aInstitute of Medicine (U.S.).$bCommittee on Clinical Trial Registries. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910452082503321 996 $aDeveloping a national registry of pharmacologic and biologic clinical trials$92122028 997 $aUNINA